Dirk Koschel

6.0k total citations
99 papers, 1.3k citations indexed

About

Dirk Koschel is a scholar working on Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Physiology. According to data from OpenAlex, Dirk Koschel has authored 99 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Pulmonary and Respiratory Medicine, 21 papers in Public Health, Environmental and Occupational Health and 17 papers in Physiology. Recurrent topics in Dirk Koschel's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (67 papers), Occupational exposure and asthma (20 papers) and Respiratory and Cough-Related Research (13 papers). Dirk Koschel is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (67 papers), Occupational exposure and asthma (20 papers) and Respiratory and Cough-Related Research (13 papers). Dirk Koschel collaborates with scholars based in Germany, United Kingdom and United States. Dirk Koschel's co-authors include Ulrich Costabel, Michael Kreuter, G. Höffken, Toby M. Maher, Paolo Spagnolo, Wim Wuyts, Martin Kolb, Francesco Bonella, Klaus-Uwe Kirchgaessler and Andreas Günther and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Annals of Oncology.

In The Last Decade

Dirk Koschel

84 papers receiving 1.2k citations

Peers

Dirk Koschel
Craig S. Glazer United States
Paul A. Greenberger United States
Roscoe C. Young United States
Roy Patterson United States
Soo Taek Uh South Korea
A Lindfors Sweden
Punchama Pacharn Thailand
Heidi Makrinioti United Kingdom
I I Coutts United Kingdom
Tadeusz M. Zielonka Poland
Craig S. Glazer United States
Dirk Koschel
Citations per year, relative to Dirk Koschel Dirk Koschel (= 1×) peers Craig S. Glazer

Countries citing papers authored by Dirk Koschel

Since Specialization
Citations

This map shows the geographic impact of Dirk Koschel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Koschel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Koschel more than expected).

Fields of papers citing papers by Dirk Koschel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Koschel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Koschel. The network helps show where Dirk Koschel may publish in the future.

Co-authorship network of co-authors of Dirk Koschel

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Koschel. A scholar is included among the top collaborators of Dirk Koschel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Koschel. Dirk Koschel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Koschel, Dirk, Francesco Bonella, Okka W. Hamer, et al.. (2024). Diagnostik und Therapie der exogen-allergischen Alveolitis. Pneumologie. 78(12). 963–1002. 1 indexed citations
3.
Kronstein‐Wiedemann, Romy, et al.. (2023). Long-COVID is Associated with Impaired Red Blood Cell Function. Hormone and Metabolic Research. 56(4). 318–323. 5 indexed citations
4.
Behr, Jürgen, Francesco Bonella, Björn C. Frye, et al.. (2023). Pharmakotherapie der idiopathischen Lungenfibrose (ein Update) und anderer progredienter pulmonaler Fibrosen. Pneumologie. 77(2). 94–119. 6 indexed citations
5.
Tesch, Falko, et al.. (2023). Validation of the qSOFA and CRB-65 in SARS-CoV-2-infected community-acquired pneumonia. ERJ Open Research. 9(3). 168–2023. 2 indexed citations
6.
Flaherty, Kevin R., Athol U. Wells, Vincent Cottin, et al.. (2021). Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial. European Respiratory Journal. 59(3). 2004538–2004538. 65 indexed citations
7.
8.
Swigris, Jeffrey J., Kevin K. Brown, Rayid Abdulqawi, et al.. (2018). Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases. European Respiratory Review. 27(150). 180075–180075. 50 indexed citations
9.
Kreuter, Michael, Jeffrey J. Swigris, David Pittrow, et al.. (2017). Quality Of Life (qol) Trajectory In Patients With Idiopathic Pulmonary Fibrosis (ipf): Longitudinal Qol Assessment Of The Insights-Ipf Registry. American Journal of Respiratory and Critical Care Medicine. 1 indexed citations
10.
Riedel, Richard, Anna Kron, Sebastian Michels, et al.. (2017). Impact of next generation TKI and co-occurring mutations in ALK-positive NSCLC patients: Results of the Network Genomic Medicine. Annals of Oncology. 28. v474–v474.
11.
Kreuter, Michael, Paolo Spagnolo, Wim Wuyts, et al.. (2017). Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone. Respiration. 93(6). 415–423. 44 indexed citations
12.
Wirtz, Heidi S., Antje Prasse, Jens Klotsche, et al.. (2016). Predictors Of Mortality In Patients With Idiopathic Pulmonary Fibrosis Under Clinical Practice Conditions: Insights-Ipf Registry. American Journal of Respiratory and Critical Care Medicine. 3 indexed citations
13.
Behr, Jürgen, Elisabeth Bendstrup, Andreas Günther, et al.. (2015). Pirfenidone and N-acetylcysteine (NAC) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF): Exploratory Efficacy Results From the PANORAMA Study. CHEST Journal. 148(4). 641A–641A. 1 indexed citations
14.
Kaderali, Lars, et al.. (2015). Retrospective survival analysis of 237 consecutive patients with multiple pulmonary metastases from advanced renal cell carcinoma exclusively resected by a 1318-nm laser. Interactive Cardiovascular and Thoracic Surgery. 21(2). 211–217. 15 indexed citations
15.
Behr, Jürgen, Michael Kreuter, Marius M. Hoeper, et al.. (2014). Late-breaking abstract: Current management of patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry. European Respiratory Journal. 44(Suppl 58). 1901–1901. 1 indexed citations
16.
Maher, Toby M., Vincent Cottin, Sara Tomassetti, et al.. (2014). S11 Pirfenidone Post-authorisation Safety Registry (passport)-interim Analysis Of Ipf Treatment. Thorax. 69(Suppl 2). A8–A9. 5 indexed citations
17.
Wiedemann, B., et al.. (2011). Forceps biopsy and suction catheter for sampling in pulmonary nodules and infiltrates. European Respiratory Journal. 39(6). 1432–1436. 7 indexed citations
18.
Schulte, W., et al.. (2010). Are there so far unknown farmer's lung antigens in Germany?. Allergologie. 33(12). 565–569.
19.
Merget, R., Dirk Koschel, Jens Schreiber, & J. Sennekamp. (2010). Hypersensitivity pneumonitis as an occupational disease - selected case reports.. Allergologie. 33(12). 544–546. 1 indexed citations
20.
Koschel, Dirk, et al.. (2005). Extrinsic allergic alveolitis caused by misting fountains. Respiratory Medicine. 99(8). 943–947. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Craig S. Glazer Breakdown of academic impact, for papers by Paul A. Greenberger Breakdown of academic impact, for papers by Roscoe C. Young Breakdown of academic impact, for papers by Roy Patterson Breakdown of academic impact, for papers by Soo Taek Uh Breakdown of academic impact, for papers by A Lindfors Breakdown of academic impact, for papers by Punchama Pacharn Breakdown of academic impact, for papers by Heidi Makrinioti Breakdown of academic impact, for papers by I I Coutts Breakdown of academic impact, for papers by Tadeusz M. Zielonka
Rankless by CCL
2026